Deborah Ramsdell

Deborah Ramsdell currently works at Valerion Therapeutics LLC, as President, Chief Executive Officer & Director from 2013, Orphan Technologies Ltd., as Director from 2015, Phoenicis Therapeutics, Inc., as President, Treasurer & Director, and Alopexx Enterprises LLC, as VP-Development Operations & Regulatory Affairs from 2011.
Ms. Ramsdell also formerly worked at Wings Therapeutics, Inc., as President & Chief Executive Officer, ImmunoGen, Inc., as Director-Regulatory Affairs & Quality Assurance, Virus Research Institute, Inc., as Director-Regulatory Affairs & Quality Assurance, Biotechnica International, Inc., as Principal, Alexion Pharmaceuticals, Inc., as VP-Regulatory Affairs & Clinical Operations, and Enobia Pharma, Inc., as VP-Regulatory Affairs & Clinical Operations.
Ms. Ramsdell received her undergraduate degree and graduate degree from Boston College.